Product Information

ERY-TAB DR 250 MG TABLET is a generic product labeled by Arbor Pharmaceuticals, Inc., priced at $1.8786 per EA under NDC 24338012203. Its NADAC has been published 432 times since Feb 7, 2018.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERY-TAB DR 250 MG TABLET

Erythromycin
$1.8786per EA

Strength

250 mg/1

NDC

24338012203

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA062298

FDA Approved

Before 1982

TE Code

AB

On Market Since

4/18/2011

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERY-TAB DR 250 MG TABLET has been published 432 times since Feb 7, 2018, and over the history we have for it it has declined 70.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8786 per EA
All-time high$7.0949 (Jul 10, 2019)
All-time low$1.6915 (Feb 18, 2026)
52-week high$2.4837
52-week low$1.6915
Median price$4.2735
Average price$4.5576
Largest weekly change+41.1% (Mar 22, 2023)
Weeks tracked432
Tracking sinceFeb 7, 2018

Price History

1W

0.0%

1M

-2.4%

3M

-19.1%

6M

-9.6%

1Y

-18.5%

3Y

-55.1%

5Y

-58.7%

All

-70.4%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERY-TAB DR 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ERY-TAB DR 250 MG TABLET, manufactured by Arbor Pharmaceuticals, Inc., is $1.8786 per EA (NDC 24338012203), effective Nov 11, 2026.

How has the price of ERY-TAB DR 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for ERY-TAB DR 250 MG TABLET has declined 70.4%. It has been tracked across 432 weekly CMS publications since Feb 7, 2018.

What are the highest and lowest recorded NADAC prices for ERY-TAB DR 250 MG TABLET?

Since Feb 7, 2018, the NADAC for ERY-TAB DR 250 MG TABLET has ranged from a low of $1.6915 (Feb 18, 2026) to a high of $7.0949 (Jul 10, 2019), with a median of $4.2735 per EA.

Are there cheaper alternatives to ERY-TAB DR 250 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ERY-TAB DR 250 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ERY-TAB DR 250 MG TABLET?

ERY-TAB DR 250 MG TABLET (NDC 24338012203) is labeled by Arbor Pharmaceuticals, Inc., and CMS classifies it as a generic product.